Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4 by Katherine Griffiths, Uli Binder, William McDowell, Rita Tommasi, Mark Frigerio, William G. Darby, Chris G. Hosking, Lionel Renaud, Matthias Machacek, Peter Lloyd, Arne Skerra, Michael Foley

Get full text